Colomer R - Search Results

1

Guidelines for HER2 testing in breast cancer: a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).

Albanell J, Andreu X, Calasanz MJ, Concha A, Corominas JM, García-Caballero T, López JA, López-Ríos F, Ramón y Cajal S, Vera-Sempere FJ, Colomer R, Martín M, Alba E, González-Martín A, Llombart A, Lluch A, Palacios J. Albanell J, et al. Among authors: colomer r. Clin Transl Oncol. 2009 Jun;11(6):363-75. doi: 10.1007/s12094-009-0370-6. Clin Transl Oncol. 2009. PMID: 19531451 Review.

2

Mitomycin-C and vinblastine in advanced breast cancer.

Navarro M, Bellmunt J, Balañá C, Colomer R, Jolis L, del Campo JM. Navarro M, et al. Among authors: colomer r. Oncology. 1989;46(3):137-42. doi: 10.1159/000226702. Oncology. 1989. PMID: 2497417 Review.

3

Paclitaxel plus doxorubicin in metastatic breast cancer: preliminary analysis of cardiotoxicity.

Martin M, Lluch A, Ojeda B, Barnabas A, Colomer R, Massuti B, Benito D. Martin M, et al. Among authors: colomer r. Semin Oncol. 1997 Oct;24(5 Suppl 17):S17-26-S17-30. Semin Oncol. 1997. PMID: 9374088 Clinical Trial.

4

Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trial.

Colomer R, Llombart A, Lluch A, Ojeda B, Barnadas A, Carañana V, Fernández Y, De Paz L, Guillem V, Alonso S. Colomer R, et al. Semin Oncol. 2000 Feb;27(1 Suppl 2):20-4. Semin Oncol. 2000. PMID: 10697032 Clinical Trial.

5

Circulating HER2 extracellular domain and resistance to chemotherapy in advanced breast cancer.

Colomer R, Montero S, Lluch A, Ojeda B, Barnadas A, Casado A, Massutí B, Cortés-Funes H, Lloveras B. Colomer R, et al. Clin Cancer Res. 2000 Jun;6(6):2356-62. Clin Cancer Res. 2000. PMID: 10873087 Clinical Trial.

6

Doxorubicin and paclitaxel in advanced breast carcinoma: importance of prior adjuvant anthracycline therapy.

Lluch A, Ojeda B, Colomer R, Barnadas A, Massuti B, Casado A, Angeles C, Maroto P. Lluch A, et al. Among authors: colomer r. Cancer. 2000 Dec 1;89(11):2169-75. doi: 10.1002/1097-0142(20001201)89:11<2169::aid-cncr4>3.0.co;2-9. Cancer. 2000. PMID: 11147586 Clinical Trial.

7

A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer.

Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R. Antón A, et al. Among authors: colomer r. Clin Breast Cancer. 2003 Oct;4(4):286-91. doi: 10.3816/cbc.2003.n.034. Clin Breast Cancer. 2003. PMID: 14651774 Clinical Trial.

8

Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain.

Colomer R, Llombart-Cussac A, Lluch A, Barnadas A, Ojeda B, Carañana V, Fernández Y, García-Conde J, Alonso S, Montero S, Hornedo J, Guillem V. Colomer R, et al. Ann Oncol. 2004 Feb;15(2):201-6. doi: 10.1093/annonc/mdh048. Ann Oncol. 2004. PMID: 14760109 Free article. Clinical Trial.

9

Validation of the 2001 St Gallen risk categories for node-negative breast cancer using a database from the Spanish Breast Cancer Research Group (GEICAM).

Colomer R, Viñas G, Beltran M, Izquierdo A, Lluch A, Llombart-Cussac A, Alba E, Munárriz B, Martín M; Spanish Breast Cancer Research Group. Colomer R, et al. J Clin Oncol. 2004 Mar 1;22(5):961-2. doi: 10.1200/JCO.2004.99.143. J Clin Oncol. 2004. PMID: 14990656 No abstract available.

10

Mediterranean diet, olive oil and cancer.

Colomer R, Menéndez JA. Colomer R, et al. Clin Transl Oncol. 2006 Jan;8(1):15-21. doi: 10.1007/s12094-006-0090-0. Clin Transl Oncol. 2006. PMID: 16632435 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters